<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is a major cause of <z:hpo ids='HP_0011420'>death</z:hpo> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Sensitive, non-invasive diagnostic screen methods are urgently needed to improve its survival rates </plain></SENT>
<SENT sid="2" pm="."><plain>Stable circulating microRNA offers unique opportunities for the early diagnosis of several diseases, including <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Our aim has been to find new plasma miRNAs that can be used as biomarkers for the detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: According to the results of miRNA profiling performed on pooling plasma samples form 10 CRC patients or 10 healthy controls, a panel of miRNAs (hsa-miR-10a, -19a, -22*, -24, -92a, 125a-5p, -141, -150, -188-3p, -192, -210, -221, -224*, -376a, -425*, -495, -572, -601, -720, -760 and hsa-let-7a, -7e) were deregulated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> plasma with fold changes &gt;5 </plain></SENT>
<SENT sid="5" pm="."><plain>After large scale validation by qRT-PCR performed on another 191 independent individuals (90 CRC, 43 advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> and 58 healthy participants), we found that the levels of plasma miR-601 and miR-760 were significantly decreased in colorectal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (<z:mp ids='MP_0002038'>carcinomas</z:mp> and advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath>) compared with healthy controls </plain></SENT>
<SENT sid="6" pm="."><plain>ROC curve analysis showed that plasma miR-601 and miR-760 were of significant diagnostic value for advanced <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>These two miRNAs together yield an AUC of 0.792 with 83.3% sensitivity and 69.1% specificity for separating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> from <z:mpath ids='MPATH_458'>normal</z:mpath> controls, and yield an AUC of 0.683 with 72.1% sensitivity and 62.1% specificity in discriminating advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> from <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/SIGNIFICANCE: Plasma miR-601 and miR-760 can potentially serve as promising non-invasive biomarkers for the early detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>